[165 Pages Report] The global urinary catheters market size is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of the urinary catheters market. However, the availability of alternative treatment options for urinary incontinence may restrict market growth to a certain extent.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 has resulted in significant disruptions to businesses and economic activities globally and is expected to have a short-term negative impact on the urinary catheters market. Urinary catheters used for surgical applications are expected to be impacted to some extent due to the temporary postponement of various elective surgeries, as governments and authorities seek to ensure the availability of resources for COVID-19 patients. In an effort to reduce the strain on the healthcare system, decrease disease transmission, and conserve personal protective equipment (PPE), various governments have provided guidelines on elective surgeries. As of March 18, 2020, the US CMS announced that all elective surgeries, as well as non-essential medical, surgical, and dental procedures, would be delayed. Other areas that are negatively impacted include the supply of products meant for hospitals (including ICUs, emergency rooms, neurological care centers, and trauma patients) due to lockdowns and mobility restrictions in various countries around the globe. However, businesses are likely to revive and resume normalcy once restrictions on elective surgeries and movement are lifted.
The high prevalence of urinary incontinence is a major factor leading to the increased demand for urinary catheters, globally. Prevalence rates are higher in the elderly population and among nursing home patients. Urinary catheters are used to manage incontinence, which cannot be treated or managed with medicines or surgery. The prevalence of urinary incontinence is expected to grow due to the growing aging population and the increasing incidence of obesity, as these are the two major risk factors for urinary incontinence further.
Catheterization is a painful process. The insertion and removal of poorly lubricated catheters can cause friction between the urethral walls and the surface of the device, which is not only painful for the patient but can also, upon regular use, lead to the narrowing of the urethra, bleeding, and infection. Special care is required during catheterization to prevent urinary tract infections (UTIs) or catheter-associated urinary tract infections (CAUTIs). As a result, there are various alternative invasive and non-invasive treatment options in place for the treatment of temporary incontinence. Their availability, given the disadvantages of catheterization, is expected to limit the market for urinary catheters.
Emerging economies (such as China, India, South Korea, Brazil, and Mexico) offer significant growth opportunities to major market players. This can be attributed to their low regulatory barriers, improvements in healthcare infrastructure, growing patient population, and rising healthcare expenditure. The regulatory policies in the Asia Pacific are more adaptive and business-friendly than those in developed countries. This, along with the increasing competition in mature markets, has drawn key players in the urinary catheters market to focus on emerging countries. For instance, in April 2018, B. Braun opened five new medical production facilities in Penang, Malaysia, and in 2017, it established a subsidiary in Zambia.
Based on catheter type, the global urinary catheters market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to register the highest CAGR during the forecast period. The growth in this market is primarily attributed to the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral damage, and improved patient satisfaction.
Based on application, the global urinary catheters market is segmented into urinary incontinence, general surgery, benign prostatic hyperplasia, and other applications. The urinary incontinence segment accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to witness the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the increasing incidence of urinary incontinence, the growing geriatric population, and the increasing incidence of obesity.
To know about the assumptions considered for the study, download the pdf brochure
The urinary catheters market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America was the largest regional segment of the overall market, followed by Europe. Factors such as the high prevalence of diseases, growing geriatric population, the availability of advanced interventional products (including urinary catheters), and increasing surgical procedures performed in the region are driving market growth in North America.
The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), and Cardinal Health (US).
Report Metric |
Details |
Market size available for years |
2018–2025 |
Base year considered |
2019 |
Forecast period |
2020–2025 |
Forecast units |
Value (USD) |
Segments covered |
Product, type, usage, application, end user, and region |
Geographies covered |
North America, Europe, Asia Pacific, and the Rest of the World |
Companies covered |
B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US), Asid Bonz GmbH (Germany), Degania Silicone Ltd. (Israel), Bactiguard (Sweden), Medical Technologies of Georgia (US), ROCAMED (Monaco), Well Lead Medical Co., Ltd. (China), Go Medical Industries Pty Ltd. (Australia), Cure Medical, LLC, Amsino International, Inc. (US), Urocare Products, Inc. (US), J and M Urinary Catheters LLC. (US), CompactCath (US), Hunter Urology (England), MANFRED SAUER GMBH (Germany), and Ribbel International Limited (India). |
This report categorizes the urinary catheters market into the following segments and subsegments:
What is the impact of COVID-19 on the urinary catheters market?
The COVID-19 (coronavirus) outbreak has disrupted business and economic activities globally. It is expected to have a short-term impact on the Urinary Catheters market to a certain extent.
Who are the key players in the urinary catheters market?
The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US).
Which product dominates in the Urinary Catheters market?
Indwelling catheters accounted for the largest share of the urinary catheters market in 2019. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market.
Which application segment of the global urinary catheters market is expected to witness the highest growth?
Urinary Incontinence application is expected to witness the highest growth.
What is the market for urinary catheters?
The global urinary catheters market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 22)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
FIGURE 1 URINARY CATHETERS MARKET
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 25)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
2.3.1 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
2.4.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.4.2 GROWTH FORECAST
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 32)
FIGURE 6 URINARY CATHETERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 URINARY CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 URINARY CATHETERS MARKET, BY USAGE, 2020-2025 (USD MILLION)
FIGURE 9 URINARY CATHETERS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 URINARY CATHETERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL URINARY CATHETERS MARKET
4 PREMIUM INSIGHTS (Page No. - 37)
4.1 URINARY CATHETERS MARKET OVERVIEW
FIGURE 12 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 ASIA PACIFIC: URINARY CATHETERS MARKET, BY APPLICATION & COUNTRY (2019)
FIGURE 13 URINARY INCONTINENCE APPLICATIONS DOMINATED THE URINARY CATHETERS MARKET IN ASIA PACIFIC IN 2019
4.3 URINARY CATHETERS MARKET, BY END USER, 2019
FIGURE 14 HOSPITALS TO BE THE LARGEST END USERS OF URINARY CATHETERS DURING THE FORECAST PERIOD
4.4 URINARY CATHETERS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 40)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 URINARY CATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of urinary incontinence
TABLE 1 GLOBAL PREVALENCE OF URINARY INCONTINENCE
5.2.1.1.1 Increasing rates of obesity
TABLE 2 PROJECTED GROWTH RATE OF OBESITY IN VARIOUS COUNTRIES
5.2.1.1.2 Rapidly increasing geriatric population
TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION)
5.2.1.2 High incidence of prostate cancer
TABLE 4 GLOBAL INCIDENCE AND PREVALENCE OF PROSTATE CANCER
5.2.1.3 Increasing number of surgical procedures
TABLE 5 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2014 VS. 2018
5.2.1.4 Favorable reimbursement scenario
5.2.2 RESTRAINTS
5.2.2.1 Complications associated with catheterization and the availability of alternatives
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.4 TRENDS
5.2.4.1 Growing preference for single-use catheters and self-catheterization
5.2.5 COVID IMPACT
5.3 PRICING ANALYSIS
TABLE 6 PRICE OF URINARY CATHETERS (USD)
5.4 VALUE CHAIN ANALYSIS
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 18 DISTRIBUTION-A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
FIGURE 19 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
6 URINARY CATHETERS MARKET, BY PRODUCT (Page No. - 51)
6.1 INTRODUCTION
TABLE 7 URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 8 URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (MILLION UNITS)
6.2 INDWELLING CATHETERS
6.2.1 INDWELLING CATHETERS TO DOMINATE THE URINARY CATHETERS MARKET DURING THE FORECAST PERIOD
TABLE 9 INDICATIONS FOR SUPRAPUBIC AND URETHRAL CATHETERIZATION
TABLE 10 INDWELLING URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 11 INDWELLING URINARY CATHETERS MARKET, BY REGION, 2018-2025 (MILLION UNITS)
6.3 INTERMITTENT CATHETERS
6.3.1 INTERMITTENT CATHETERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
TABLE 12 INTERMITTENT URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 13 INTERMITTENT URINARY CATHETERS MARKET, BY REGION, 2018-2025 (MILLION UNITS)
6.4 EXTERNAL CATHETERS
6.4.1 ADVANTAGES SUCH AS MINIMIZED RISK OF DAMAGE TO THE URETHRA TO DRIVE THE MARKET FOR EXTERNAL CATHETERS
TABLE 14 EXTERNAL URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 15 EXTERNAL URINARY CATHETERS MARKET, BY REGION, 2018-2025 (MILLION UNITS)
7 URINARY CATHETERS MARKET, BY TYPE (Page No. - 57)
7.1 INTRODUCTION
TABLE 16 URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.2 COATED CATHETERS
7.2.1 COATED CATHETERS ARE THE LARGEST AND FASTEST-GROWING SEGMENT IN THE URINARY CATHETERS MARKET
TABLE 17 COATED URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
7.3 UNCOATED CATHETERS
7.3.1 AFFORDABLE PRICE AND EASY AVAILABILITY TO DRIVE THE MARKET FOR UNCOATED CATHETERS
TABLE 18 ADVANTAGES AND DISADVANTAGES OF COMMONLY USED URINARY CATHETER MATERIALS
TABLE 19 UNCOATED URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
8 URINARY CATHETERS MARKET, BY USAGE (Page No. - 62)
8.1 INTRODUCTION
TABLE 20 URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
8.2 MALE URINARY CATHETERS
8.2.1 HIGH INCIDENCE OF PROSTATE CANCER TO DRIVE THE MARKET FOR MALE URINARY CATHETERS
TABLE 21 MALE URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
8.3 FEMALE URINARY CATHETERS
8.3.1 HIGH PREVALENCE OF URINARY INCONTINENCE TO DRIVE THE MARKET FOR FEMALE URINARY CATHETERS
TABLE 22 FEMALE URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
9 URINARY CATHETERS MARKET, BY APPLICATION (Page No. - 65)
9.1 INTRODUCTION
TABLE 23 URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
9.2 URINARY INCONTINENCE
9.2.1 URINARY INCONTINENCE APPLICATION SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 24 URINARY CATHETERS MARKET FOR URINARY INCONTINENCE APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
9.3 GENERAL SURGERY
9.3.1 INCREASING NUMBER OF SURGERIES TO DRIVE MARKET GROWTH
TABLE 25 URINARY CATHETERS MARKET FOR GENERAL SURGERY APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
9.4 BENIGN PROSTATIC HYPERPLASIA
9.4.1 GROWING GLOBAL PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA TO DRIVE THE DEMAND FOR URINARY CATHETERS
TABLE 26 URINARY CATHETERS MARKET FOR BENIGN PROSTATIC HYPERPLASIA APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
9.5 OTHER APPLICATIONS
TABLE 27 URINARY CATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
10 URINARY CATHETERS MARKET, BY END USER (Page No. - 70)
10.1 INTRODUCTION
TABLE 28 URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
10.2 HOSPITALS
10.2.1 HIGH PATIENT INFLUX AND PROCEDURAL VOLUMES MAKE HOSPITALS THE LARGEST END USERS OF URINARY CATHETERS
TABLE 29 URINARY CATHETERS MARKET FOR HOSPITALS, BY REGION, 2018-2025 (USD MILLION)
10.3 LONG-TERM CARE FACILITIES
10.3.1 GROWING DEMAND FOR LONG-TERM CARE SUPPORTS THE GROWTH OF THIS END-USER SEGMENT
TABLE 30 URINARY CATHETERS MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2018-2025 (USD MILLION)
10.4 OTHER END USERS
TABLE 31 URINARY CATHETERS MARKET FOR OTHER END USERS, BY REGION, 2018-2025 (USD MILLION)
11 URINARY CATHETERS MARKET, BY REGION (Page No. - 74)
11.1 INTRODUCTION
TABLE 32 URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: URINARY CATHETERS MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: URINARY CATHETERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 34 NORTH AMERICA: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 35 NORTH AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 36 NORTH AMERICA: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 37 NORTH AMERICA: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 38 NORTH AMERICA: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominates the North American market
TABLE 39 US: KEY MACROINDICATORS
TABLE 40 US: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 41 US: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 42 US: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 43 US: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 44 US: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Rising prevalence of target diseases to positively impact the market in Canada
TABLE 45 CANADA: KEY MACROINDICATORS
TABLE 46 CANADA: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 47 CANADA: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 48 CANADA: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 49 CANADA: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 50 CANADA: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3 EUROPE
TABLE 51 EUROPE: URINARY CATHETERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 52 EUROPE: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 53 EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 54 EUROPE: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 55 EUROPE: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 56 EUROPE: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany holds the largest share of the urinary catheters market in Europe
TABLE 57 GERMANY: KEY MACROINDICATORS
TABLE 58 GERMANY: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 59 GERMANY: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 60 GERMANY: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 61 GERMANY: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 62 GERMANY: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.2 UK
11.3.2.1 Large number of road accidents to drive the market for urinary catheters in the country
TABLE 63 UK: KEY MACROINDICATORS
TABLE 64 UK: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 65 UK: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 66 UK: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 67 UK: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 68 UK: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 Favorable government initiatives have supported market growth in France
TABLE 69 FRANCE: KEY MACROINDICATORS
TABLE 70 FRANCE: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 71 FRANCE: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 72 FRANCE: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 73 FRANCE: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 74 FRANCE: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Increasing healthcare expenditure and investments are driving the market in Italy
TABLE 75 ITALY: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 76 ITALY: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 77 ITALY: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 78 ITALY: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 79 ITALY: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Rising geriatric population will aid the market growth
TABLE 80 SPAIN: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 81 SPAIN: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 82 SPAIN: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 83 SPAIN: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 84 SPAIN: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.6 REST OF EUROPE (ROE)
TABLE 85 ROE: CANCER CASES AND PROSTATE CANCER (%), BY COUNTRY, 2018
TABLE 86 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2006 VS. 2016 (% OF GDP)
TABLE 87 ROE: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 88 ROE: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 89 ROE: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 90 ROE: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 91 ROE: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: URINARY CATHETERS MARKET SNAPSHOT
TABLE 92 APAC: URINARY CATHETERS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 93 APAC: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 94 APAC: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 95 APAC: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 96 APAC: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 97 APAC: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Japan dominates the Asia Pacific market
TABLE 98 JAPAN: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 99 JAPAN: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 100 JAPAN: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 101 JAPAN: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 102 JAPAN: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Improvements in healthcare infrastructure will favor market growth in China
TABLE 103 CHINA: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 104 CHINA: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 105 CHINA: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 106 CHINA: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 107 CHINA: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 High incidence of target medical conditions to drive the market for urinary catheters in the country
TABLE 108 INDIA: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 109 INDIA: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 110 INDIA: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 111 INDIA: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 112 INDIA: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.4 REST OF ASIA PACIFIC
TABLE 113 ROAPAC: CANCER CASES AND PROSTATE CANCER (%), BY COUNTRY, 2018
TABLE 114 ROAPAC: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 115 ROAPAC: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 116 ROAPAC: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 117 ROAPAC: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 118 ROAPAC: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
11.5 ROW
TABLE 119 ROW: NEW CANCER CASES AND PROSTATE CANCER (%), BY COUNTRY, 2018
TABLE 120 ROW: URINARY CATHETERS MARKET, BY REGION, 2018-2025 (USD MILLION)
TABLE 121 ROW: URINARY CATHETERS MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 122 ROW: URINARY CATHETERS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 123 ROW: URINARY CATHETERS MARKET, BY USAGE, 2018-2025 (USD MILLION)
TABLE 124 ROW: URINARY CATHETERS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 125 ROW: URINARY CATHETERS MARKET, BY END USER, 2018-2025 (USD MILLION)
12 COMPETITIVE LANDSCAPE (Page No. - 112)
12.1 OVERVIEW
FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
FIGURE 23 MARKET EVOLUTION FRAMEWORK
12.2 COMPETITIVE SITUATIONS AND TRENDS
12.2.1 PARTNERSHIPS & AGREEMENTS
12.2.2 PRODUCT LAUNCHES & APPROVALS
12.2.3 EXPANSIONS
12.2.4 ACQUISITIONS
13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 116)
13.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
13.1.1 MARKET SHARE ANALYSIS, 2019
FIGURE 24 URINARY CATHETERS MARKET, BY KEY PLAYER, 2019
13.2 COMPANY EVALUATION MATRIX
13.2.1 STARS
13.2.2 EMERGING LEADERS
13.2.3 PERVASIVE PLAYERS
13.2.4 PARTICIPANTS
FIGURE 25 MNM VENDOR DIVE COMPARISON MATRIX: URINARY CATHETERS MARKET
13.3 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
13.3.1 PROGRESSIVE COMPANIES
13.3.2 STARTING BLOCKS
13.3.3 RESPONSIVE COMPANIES
13.3.4 DYNAMIC COMPANIES
FIGURE 26 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: URINARY CATHETERS MARKET
13.4 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.4.1 COLOPLAST A/S
FIGURE 27 COLOPLAST A/S: COMPANY SNAPSHOT
13.4.2 BECTON, DICKINSON AND COMPANY (BD)
FIGURE 28 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
13.4.3 CONVATEC GROUP PLC
FIGURE 29 CONVATEC GROUP PLC: COMPANY SNAPSHOT
13.4.4 CARDINAL HEALTH
FIGURE 30 CARDINAL HEALTH: COMPANY SNAPSHOT
13.4.5 B. BRAUN MELSUNGEN AG
FIGURE 31 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
13.4.6 BOSTON SCIENTIFIC CORPORATION
FIGURE 32 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
13.4.7 ASID BONZ GMBH
13.4.8 BACTIGUARD
FIGURE 33 BACTIGUARD: COMPANY SNAPSHOT
13.4.9 COOK MEDICAL
13.4.10 CURE MEDICAL
13.4.11 GO MEDICAL INDUSTRIES PTY LTD.
13.4.12 HOLLISTER INCORPORATED
13.4.13 TELEFLEX INCORPORATED
FIGURE 34 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
13.4.14 WELLSPECT HEALTHCARE (A SUBSIDIARY OF DENTSPLY SIRONA INC.)
FIGURE 35 DENTSPLY SIRONA: COMPANY SNAPSHOT
13.5 OTHER COMPANIES
13.5.1 AMSINO INTERNATIONAL, INC.
13.5.2 COMPACTCATH
13.5.3 DEGANIA SILICONE LTD. (A PART OF Q LIFE SCIENCES)
13.5.4 HUNTER UROLOGY
13.5.5 J AND M URINARY CATHETERS LLC
13.5.6 MANFRED SAUER GMBH
13.5.7 MEDICAL TECHNOLOGIES OF GEORGIA
13.5.8 RIBBEL INTERNATIONAL LIMITED
13.5.9 ROCAMED
13.5.10 UROCARE PRODUCTS, INC.
13.5.11 WELL LEAD MEDICAL CO., LTD.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
14 APPENDIX (Page No. - 158)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the urinary catheters market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the urinary catheters market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), National Center for Biotechnology Information (NCBI), Centers for Disease Control and Prevention (CDC), US Food and Drug Administration (US FDA), National Institutes of Health (NIH), National Cancer Institute (NCI), National Association for Continence (NAFC), Urology Care Foundation, Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the urinary catheters market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Growth opportunities and latent adjacency in Urinary Catheters Market